Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Vitamin D levels appear to play role in COVID-19 mortality rates
Vitamin D levels appear to play role in COVID-19 mortality rates
After studying global data from the novel coronavirus (COVID-19) pandemic, researchers have discovered a strong correlation between severe vitamin D deficiency and mortality rates.
Gilead hit with Iranian cyberattack for role in COVID-19 response: report
Gilead hit with Iranian cyberattack for role in COVID-19 response: report
Gilead Sciences has captured worldwide attention since its antiviral drug remdesivir was approved late last week as the first therapy to treat COVID-19.
Cadila shutters Indian ingredients plant after 26 workers test positive for COVID-19
Cadila shutters Indian ingredients plant after 26 workers test positive for COVID-19
Global drugmakers are working overtime to keep supplies coming amid the novel coronavirus pandemic.
Certara and DMTC announce research collaboration to study preventative use of chloroquine in health care workers at high risk for Covid-19
Certara and DMTC announce research collaboration to study preventative use of chloroquine in health care workers at high risk for Covid-19
Certara, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical counter...
Daiichi Sankyo submits sNDA for trastuzumab deruxtecan in Japan for HER2 positive metastatic gastric cancer
Daiichi Sankyo submits sNDA for trastuzumab deruxtecan in Japan for HER2 positive metastatic gastric cancer
Daiichi Sankyo has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for trastuzumab deruxtecan (DS-8201), a HER2 ...
Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial
Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial
MONTREAL--- Laurent Pharmaceuticals Inc.
Novartis gets FDA nod for Tabrecta to treat metastatic NSCLC with METex14
Novartis gets FDA nod for Tabrecta to treat metastatic NSCLC with METex14
Novartis has secured approval from the US Food and Drug Administration (FDA) for its Tabrecta (capmatinib) to treat adult patients metastatic non-small cell lung cancer (NSCLC)...
Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials
Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials
German drugmaker Fresenius Kabi has made major investments in its U.
Janssen promotes R&D exec into newfound data science role
Janssen promotes R&D exec into newfound data science role
Following in the footsteps of an increasing number of biopharmas that want to use data to get more bang for their buck in R&D, Johnson & Johnson has promoted Najat Khan, Ph.
Avrobio taps Magenta’s ADC in ongoing quest to improve gene therapy conditioning
Avrobio taps Magenta’s ADC in ongoing quest to improve gene therapy conditioning
Avrobio is working to make conditioning, a necessary step for some gene therapies, safer.
With the world waiting, Roche socks $459M into COVID-19 antibody test production
With the world waiting, Roche socks $459M into COVID-19 antibody test production
Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality.
Gilead, working on its own remdesivir ramp-up, scouts licensing partners for global production
Gilead, working on its own remdesivir ramp-up, scouts licensing partners for global production
Gilead Sciences can only produce so much of its newly authorized COVID-19 drug remdesivir, so it’s scouting other companies to bolster global supply.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand